Northpond Ventures II, LP
SEC CIK 1869128 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CAMP | Camp4 Therapeutics Corp | 10% | 471.4K | $8.40M | — | 2 | 2024-10-15 | 2024-10-15 |
Most active insiders at CAMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schwab Andrew J. | Dir | — | $2.50M |
| 2 | Gold Kelly | CFO | $50.4K | — |
| 3 | Young Richard A | Dir | $27.0K | — |
| 4 | Mandel-Brehm Josh | CEO, Dir | $10.8K | — |
| 5 | Maricich Yuri | Chief Medical Off | $10.8K | — |
| 6 | Tardiff Daniel | CSO | — | $8,273 |
Northpond Ventures II, LP made no open-market trades at CAMP in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-10-17 | 2024-10-15 | CAMP | Camp4 Therapeutics Corp | Northpond Ventures II, LP | 10% | C - Cnv Deriv | — | +1.47M | 471.4K | New | — |
| DI | 2024-10-17 | 2024-10-15 | CAMP | Camp4 Therapeutics Corp | Northpond Ventures II, LP | 10% | P - Purchase | $11.00 | +763.6K | 763.6K | New | +$8.40M |
Purchase Sale Sale after option exercise All abbreviations